PROM1 and prostate carcinoma: Recent study discovered that it could express on leukemia cells, brain gliomas, colon cancer cells, prostate cancer cells, liver cancer cells and pancreatic cancer cells, which illustrates that CD133 positive tumor cells are capable of stronger ability of proliferation, differentiation and self-renewal [39, 40].